The IBD-FITT Study - Moderate-intensity Exercise for IBD Patients With Moderate Disease Activity
- Conditions
- Inflammatory Bowel Diseases
- Interventions
- Behavioral: Lifestyle - online lesson interventionBehavioral: Exercise intervention
- Registration Number
- NCT04816812
- Lead Sponsor
- University of Southern Denmark
- Brief Summary
The investigators aim to investigate whether exercise therapy during 12 weeks including a lesson on general healthy lifestyle in adult patients with a moderately active disease is more effective, compared to control patients only receiving a lesson on general healthy lifestyle recommendations. The three main categories of outcomes are 1) health-related quality of life, 2) general health status of the patients 3) explorative outcomes. The primary outcome is health-related quality of life, the secondary outcome is general health status measured by waist circumference, disease activity scores, blood pressure, and blood lipids, and the third outcome are explorative outcomes (none-disease specific quality of life scores, biomarkers of C-reactive protein, fecal calprotectin and immunology markers including interleukins).
- Detailed Description
The investigators will apply a superior trial design in this randomized clinical trial with two arms, intervention and comparison. In both the intervention and comparison arm, the patients will receive the proper and usual medical treatment decided by their responsible physician and changes in the medical treatment is allowed at all times.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 44
-
Patients with moderately active Crohn's disease or ulcerative colitis are defined by fulfilling all the following five criteria:
-
Well-characterized Crohn's disease or ulcerative colitis (physician assessment) i. Fulfilling standard clinical, endoscopic, radiologic, and histological criteria
-
A minimum of one-year disease duration from the time of diagnosis of Crohn's disease or ulcerative colitis to inclusion into the trial
-
Any of the following pharmacological treatments in a period of three months prior to inclusion:
i. Usage of 5-Aminosalicylic acid (5-ASA) ii. Usage of corticosteroids iii. Immunomodulators usage: Azathioprine (AZA), 6-mercaptopurine (6-MP), Methotrexate (MTX) iv. Biologics usage: Anti-TNFα (Infliximab, Adalimumab, Golimumab), Ustekinumab or Anti-integrin (Vedolizumab)
-
Disease activity defined by clinical disease score:
i. Harvey Bradshaw Index (HBI) 27 > 5 ii. Simple Clinical Colitis Activity Index (SCCAI) 29 > 5
-
Marker for gastrointestinal inflammation:
i. Fecal calprotectin (FC) > 200 mg/g
-
-
-
A language barrier that prohibits the exercise instructors/supervisors to give sufficient or safe instructions during the intervention or at the general health lesson.
-
Known heart condition that prevents them to actively participate safely in the exercise intervention.
-
Known pregnancy or planned pregnancy. 4. Disabling musculoskeletal injuries that prevent them to actively participate in the exercise intervention.
-
Severe disease activity manifested clinically and with the need for urgent change in treatment evaluated by the responsible physician.
-
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Comparison Lifestyle - online lesson intervention Comparison Exercise Lifestyle - online lesson intervention In the intervention arm, a 12-week aerobic exercise program tailored to the individual patients by physiotherapists using the principles of Frequency, Intensity, Time, and, Type (FITT) aiming to increase or maintain the physical activity level to a weekly moderate activity level. Exercise Exercise intervention In the intervention arm, a 12-week aerobic exercise program tailored to the individual patients by physiotherapists using the principles of Frequency, Intensity, Time, and, Type (FITT) aiming to increase or maintain the physical activity level to a weekly moderate activity level.
- Primary Outcome Measures
Name Time Method Inflammatory Bowel Disease Questionnaire (IBDQ) 12 weeks Health-related quality of life
- Secondary Outcome Measures
Name Time Method General health - blood pressure 12 weeks Blood pressure
General health - Waist circumference 12 weeks Waist circumference
General health - Lipid 12 weeks Lipid status:
i. Low-density lipoprotein (LDL) ii. High-density lipoprotein (HDL) iii. Triglycerides iv. Total cholesterol v. Hemoglobin A (Hbac1)General health - Clinical disease activity 12 weeks Harvey Bradshaw Index (Crohn's disease) Simple Clinical Colitis Activity Index (Ulcerative colitis)
Trial Locations
- Locations (2)
Hospital of Southwest Jutland
🇩🇰Esbjerg, Denmark
Odense University Hospital
🇩🇰Odense, Denmark